S&P 500   4,320.06
DOW   33,963.84
QQQ   356.31
3 Blue Chip Safe Havens to Shield Your Portfolio
Would Buffett Approve of This Growth Strategy? (Ad)
Buy The World’s Largest IT Infrastructure Provider For Under $20
3 Stocks That Flourish In The Fall
Would Buffett Approve of This Growth Strategy? (Ad)
Stock market today: Wall Street inches lower hinting that sustained market sell-off may continue
Oil prices have risen. That's making gas more expensive for US drivers and helping Russia's war
Would Buffett Approve of This Growth Strategy? (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
S&P 500   4,320.06
DOW   33,963.84
QQQ   356.31
3 Blue Chip Safe Havens to Shield Your Portfolio
Would Buffett Approve of This Growth Strategy? (Ad)
Buy The World’s Largest IT Infrastructure Provider For Under $20
3 Stocks That Flourish In The Fall
Would Buffett Approve of This Growth Strategy? (Ad)
Stock market today: Wall Street inches lower hinting that sustained market sell-off may continue
Oil prices have risen. That's making gas more expensive for US drivers and helping Russia's war
Would Buffett Approve of This Growth Strategy? (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
S&P 500   4,320.06
DOW   33,963.84
QQQ   356.31
3 Blue Chip Safe Havens to Shield Your Portfolio
Would Buffett Approve of This Growth Strategy? (Ad)
Buy The World’s Largest IT Infrastructure Provider For Under $20
3 Stocks That Flourish In The Fall
Would Buffett Approve of This Growth Strategy? (Ad)
Stock market today: Wall Street inches lower hinting that sustained market sell-off may continue
Oil prices have risen. That's making gas more expensive for US drivers and helping Russia's war
Would Buffett Approve of This Growth Strategy? (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
S&P 500   4,320.06
DOW   33,963.84
QQQ   356.31
3 Blue Chip Safe Havens to Shield Your Portfolio
Would Buffett Approve of This Growth Strategy? (Ad)
Buy The World’s Largest IT Infrastructure Provider For Under $20
3 Stocks That Flourish In The Fall
Would Buffett Approve of This Growth Strategy? (Ad)
Stock market today: Wall Street inches lower hinting that sustained market sell-off may continue
Oil prices have risen. That's making gas more expensive for US drivers and helping Russia's war
Would Buffett Approve of This Growth Strategy? (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
OTCMKTS:TCNNF

Trulieve Cannabis (TCNNF) Stock Forecast, Price & News

$6.19
+0.07 (+1.14%)
(As of 09/22/2023 08:53 PM ET)
Compare
Today's Range
$6.02
$6.36
50-Day Range
$3.45
$7.45
52-Week Range
$3.42
$16.11
Volume
260,900 shs
Average Volume
387,087 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$43.33

TCNNF stock logo

About Trulieve Cannabis (OTCMKTS:TCNNF) Stock

Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. The company cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, as well as through home delivery. It produces flowers, edibles, vaporizer cartridge, concentrates, topicals, capsules, tinctures, dissolvable powders, and nasal sprays under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, and Roll One brands. The company operates dispensaries in Florida, Arizona, Georgia, California, Maryland, Massachusetts, West Virginia, and Connecticut; and affiliated dispensaries in Pennsylvania. It also operated cultivation and processing facilities in Arizona, Colorado, Florida, Georgia, Maryland, Massachusetts, Pennsylvania, and West Virginia. The company was formerly known as Schyan Exploration Inc./Exploration Schyan Inc. and changed its name to Trulieve Cannabis Corp. in September 2018. Trulieve Cannabis Corp. was incorporated in 1940 and is headquartered in Quincy, Florida.

TCNNF Price History

TCNNF Stock News Headlines

Would Buffett Approve of This Growth Strategy?
Warren Buffett's approach has been to find and invest in undervalued businesses with strong potential for growth. Taking this approach to heart and applying it to a Trillion Dollar industry has proved itself in a big way...achieving an incredible 400+% growth during a down market.
Would Buffett Approve of This Growth Strategy?
Warren Buffett's approach has been to find and invest in undervalued businesses with strong potential for growth. Taking this approach to heart and applying it to a Trillion Dollar industry has proved itself in a big way...achieving an incredible 400+% growth during a down market.
Trulieve Announces September 2023 Event Participation
Trulieve Q2 Revenue Declines 10% YoY, What About Adjusted EBITDA?
Craig-Hallum Reaffirms Their Hold Rating on Trulieve Cannabis (TCNNF)
See More Headlines
Receive TCNNF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trulieve Cannabis and its competitors with MarketBeat's FREE daily newsletter.

TCNNF Company Calendar

Last Earnings
11/15/2021
Today
9/24/2023
Next Earnings (Estimated)
11/07/2023

Industry, Sector and Symbol

Industry
Drug Manufacturers—Specialty & Generic
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:TCNNF
Fax
N/A
Employees
5,900
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$43.33
High Stock Price Forecast
$132.00
Low Stock Price Forecast
$6.00
Forecasted Upside/Downside
+600.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Ms. Kimberly Rivers (Age 45)
    Founder, Chairman & CEO
    Comp: $739.44k
  • Mr. Eric Raymond Powers III (Age 54)
    J.D., Chief Legal Officer & Corp. Sec.
    Comp: $507.76k
  • Mr. Timothy Morey (Age 60)
    Chief Sales Officer
    Comp: $404.76k
  • Mr. Kyle Landrum (Age 37)
    Chief Production Officer
    Comp: $411.96k
  • Mr. Steven Mathew White (Age 49)
    Pres
  • Mr. Ryan Blust
    Interim CFO, Controller & Director of Financial Reporting
  • Ms. Joy Malivuk (Age 48)
    VP & Chief Accounting Officer
  • Mr. Nilyum Jhala
    Chief Technology Officer
  • Mr. Jason Barry Pernell (Age 45)
    Chief Information Officer
  • Ms. Christine Hersey
    Director of Investor Relations













TCNNF Stock - Frequently Asked Questions

Should I buy or sell Trulieve Cannabis stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Trulieve Cannabis in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" TCNNF shares.
View TCNNF analyst ratings
or view top-rated stocks.

What is Trulieve Cannabis' stock price forecast for 2023?

3 brokers have issued 12 month price objectives for Trulieve Cannabis' shares. Their TCNNF share price forecasts range from $6.00 to $132.00. On average, they predict the company's stock price to reach $43.33 in the next year. This suggests a possible upside of 600.1% from the stock's current price.
View analysts price targets for TCNNF
or view top-rated stocks among Wall Street analysts.

How have TCNNF shares performed in 2023?

Trulieve Cannabis' stock was trading at $7.57 at the beginning of the year. Since then, TCNNF shares have decreased by 18.2% and is now trading at $6.19.
View the best growth stocks for 2023 here
.

When is Trulieve Cannabis' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 7th 2023.
View our TCNNF earnings forecast
.

How were Trulieve Cannabis' earnings last quarter?

Trulieve Cannabis Corp. (OTCMKTS:TCNNF) released its quarterly earnings results on Monday, November, 15th. The company reported $0.14 EPS for the quarter, missing the consensus estimate of $0.27 by $0.13.

What is Trulieve Cannabis' stock symbol?

Trulieve Cannabis trades on the OTCMKTS under the ticker symbol "TCNNF."

How do I buy shares of Trulieve Cannabis?

Shares of TCNNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Trulieve Cannabis' stock price today?

One share of TCNNF stock can currently be purchased for approximately $6.19.

How many employees does Trulieve Cannabis have?

The company employs 5,900 workers across the globe.

How can I contact Trulieve Cannabis?

Trulieve Cannabis' mailing address is 6749 Ben Bostic Road, Quincy, FL 32351. The official website for the company is www.trulieve.com. The company can be reached via phone at (850) 480-7955.

This page (OTCMKTS:TCNNF) was last updated on 9/25/2023 by MarketBeat.com Staff

My Account -